0.897
price up icon0.79%   0.007
after-market Dopo l'orario di chiusura: .87 -0.027 -3.01%
loading
Precedente Chiudi:
$0.89
Aprire:
$0.902
Volume 24 ore:
143.65K
Relative Volume:
0.04
Capitalizzazione di mercato:
$6.19M
Reddito:
-
Utile/perdita netta:
$-9.62M
Rapporto P/E:
-0.1442
EPS:
-6.22
Flusso di cassa netto:
$-7.93M
1 W Prestazione:
-8.04%
1M Prestazione:
+8.60%
6M Prestazione:
-25.87%
1 anno Prestazione:
-28.24%
Intervallo 1D:
Value
$0.8873
$0.935
Intervallo di 1 settimana:
Value
$0.85
$0.9757
Portata 52W:
Value
$0.58
$1.73

Hoth Therapeutics Inc Stock (HOTH) Company Profile

Name
Nome
Hoth Therapeutics Inc
Name
Telefono
(646)756-2997
Name
Indirizzo
590 MADISON AVENUE, NEW YORK, NY
Name
Dipendente
3
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
HOTH's Discussions on Twitter

Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2019-10-15 Iniziato The Benchmark Company Speculative Buy

Hoth Therapeutics Inc Borsa (HOTH) Ultime notizie

pulisher
Nov 04, 2024

Hoth Therapeutics shares hold buy as study shows cancer treatment promise - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Hoth Therapeutics Receives Notification from Nasdaq Due to Minimum Bid Price Non-Compliance - Defense World

Nov 04, 2024
pulisher
Nov 01, 2024

Hoth Therapeutics faces Nasdaq delisting over stock price - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

Hoth Therapeutics faces Nasdaq delisting over stock price By Investing.com - Investing.com UK

Nov 01, 2024
pulisher
Oct 30, 2024

Hoth Therapeutics reports stable tumor growth in study By Investing.com - Investing.com Canada

Oct 30, 2024
pulisher
Oct 29, 2024

Hoth Therapeutics Up 34% on Favorable Early Data for Preclinical Study of Cancer Drug - MarketWatch

Oct 29, 2024
pulisher
Oct 29, 2024

Hoth Therapeutics reports stable tumor growth in study - Investing.com

Oct 29, 2024
pulisher
Oct 29, 2024

Hoth Therapeutics Announces Update on Cancer Therapeutic HT-KIT Results Suggesting the Treatment Effectively Inhibited Tumor Growth in Preclinical Treatment Study - PR Newswire

Oct 29, 2024
pulisher
Oct 16, 2024

Top investors say Hoth Therapeutics Inc (HOTH) ticks everything they need - SETE News

Oct 16, 2024
pulisher
Oct 16, 2024

Hoth Therapeutics Inc [HOTH] Is Currently 8.11 above its 200 Period Moving Avg: What Does This Mean? - The DBT News

Oct 16, 2024
pulisher
Oct 16, 2024

Hoth Therapeutics secures patent, analyst maintains steady target - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

Hoth Therapeutics secures patent, analyst maintains steady target By Investing.com - Investing.com UK

Oct 16, 2024
pulisher
Oct 16, 2024

Hoth Therapeutics secures US patent for Alzheimer's drug By Investing.com - Investing.com Australia

Oct 16, 2024
pulisher
Oct 15, 2024

HOTH’s Stock Market Adventure: -43.06% YTD Growth Amidst Volatility - The InvestChronicle

Oct 15, 2024
pulisher
Oct 15, 2024

Hoth Therapeutics secures US patent for Alzheimer's drug - Investing.com India

Oct 15, 2024
pulisher
Oct 15, 2024

Financial Metrics Check: Hoth Therapeutics Inc (HOTH)’s Ratios for Trailing Twelve Months - The Dwinnex

Oct 15, 2024
pulisher
Oct 15, 2024

Hoth Shares Rise After Alzheimer's Treatment Gets Patent - MarketWatch

Oct 15, 2024
pulisher
Oct 15, 2024

Hoth Therapeutics Awarded Key US Patent for Groundbreaking Alzheimer's Treatment and Prepares for Clinical Trials of HT-ALZ with Formulation Now Underway - PR Newswire

Oct 15, 2024
pulisher
Oct 12, 2024

Benchmark keeps Speculative Buy rating on Hoth shares on robust pipeline By Investing.com - Investing.com Canada

Oct 12, 2024
pulisher
Oct 11, 2024

Benchmark keeps Speculative Buy rating on Hoth shares on robust pipeline - Investing.com

Oct 11, 2024
pulisher
Oct 06, 2024

Hoth Therapeutics, Wise Systems Partner To Leverage AI For Drug Discovery - Contract Pharma

Oct 06, 2024
pulisher
Oct 02, 2024

Micro Cap Already Off To The Races At The Bell - MSN

Oct 02, 2024
pulisher
Sep 30, 2024

Hoth Therapeutics, Inc. (NASDAQ:HOTH) Sees Significant Increase in Short Interest - Defense World

Sep 30, 2024
pulisher
Sep 25, 2024

EGFR Inhibitors-Induced Skin Disorders Market Growth - openPR

Sep 25, 2024
pulisher
Sep 24, 2024

Buy Honasa Consumer, target price Rs 530: JM Financial - The Economic Times

Sep 24, 2024
pulisher
Sep 23, 2024

Examining the Potential Price Growth of Holley Inc (HLLY) - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 4% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Harrow Inc (HROW) Becoming More Attractive for Investors - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Davidson Kempner Capital Management LP Invests $3.21 Million in Loar Holdings, LLC (NYSE:LOAR) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Why Investors Shouldn't Be Surprised By THOR Industries, Inc.'s (NYSE:THO) P/E - Simply Wall St

Sep 23, 2024
pulisher
Sep 23, 2024

Lombard Odier Asset Management USA Corp Invests $786,000 in Hilton Grand Vacations Inc. (NYSE:HGV) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

THG Plunges 24% ATO amid Internal Frauds by Subsidiaries - KAOHOON INTERNATIONAL

Sep 23, 2024
pulisher
Sep 22, 2024

Holley Inc. (NYSE:HLLY) Shares Sold by Kayne Anderson Rudnick Investment Management LLC - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Capstone Triton Financial Group LLC Has $707,000 Stock Position in Honeywell International Inc. (NASDAQ:HON) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Hoth Therapeutics (NASDAQ:HOTH) Trading Down 3% - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

Highbridge Capital Management LLC Purchases Shares of 630,114 HashiCorp, Inc. (NASDAQ:HCP) - MarketBeat

Sep 20, 2024
pulisher
Sep 19, 2024

Haoxi Health Technology Down 75% After $12M Offering - MarketWatch

Sep 19, 2024
pulisher
Sep 19, 2024

The time has not yet come to remove your chips from the table: Hoth Therapeutics Inc (HOTH) - SETE News

Sep 19, 2024
pulisher
Sep 18, 2024

Hoth Therapeutics Inc (HOTH) gets rating Initiated from The Benchmark Company - Knox Daily

Sep 18, 2024
pulisher
Sep 18, 2024

Hoth Therapeutics Inc [HOTH] Revenue clocked in at $0.00 million, down -25.69% YTD: What’s Next? - The DBT News

Sep 18, 2024
pulisher
Sep 18, 2024

Balance Sheet Dive: Hoth Therapeutics Inc (HOTH)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Sep 18, 2024
pulisher
Sep 18, 2024

Choreo LLC Purchases New Shares in The Hanover Insurance Group, Inc. (NYSE:THG) - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

C4 Therapeutics Inc (NASDAQ: CCCC) Up 14.34% This Year: What To Expect Next - Stocks Register

Sep 18, 2024
pulisher
Sep 17, 2024

Hoth Therapeutics Inc (HOTH) Stock: Navigating a Year of Volatility - The InvestChronicle

Sep 17, 2024
pulisher
Sep 17, 2024

Hoth Therapeutics Shares Rally on Positive Alzheimer's Pre-clinical Study Data - MarketWatch

Sep 17, 2024
pulisher
Sep 17, 2024

Hoth Therapeutics Announces Promising Preclinical Results for Alzheimer's Drug HT-ALZ - PR Newswire

Sep 17, 2024
pulisher
Sep 12, 2024

Monopar Therapeutics' (MNPR) MNPR-101-Zr Shows Promising Tumor Targeting in Early Clinical Trial - BP Journal

Sep 12, 2024
pulisher
Sep 11, 2024

Hoth Therapeutics Inc (HOTH) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News

Sep 11, 2024
pulisher
Sep 11, 2024

Market Watch Highlights: Hoth Therapeutics Inc (HOTH) Ends on an Upturn Note at 1.12 - The Dwinnex

Sep 11, 2024
pulisher
Sep 10, 2024

Hoth Therapeutics Inc [HOTH] Stock bought by Insider Knie Robb for $16750.0 - Knox Daily

Sep 10, 2024
pulisher
Sep 10, 2024

AstraZeneca (NASDAQ: AZN) Stock Dips on Lung Cancer Drug Trial Setback - ABBO News

Sep 10, 2024

Hoth Therapeutics Inc Azioni (HOTH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):